메뉴 건너뛰기




Volumn 48, Issue 2, 2012, Pages e2-

A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

EID: 84856331700     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.07.030     Document Type: Letter
Times cited : (37)

References (9)
  • 1
    • 33646836925 scopus 로고    scopus 로고
    • Systematic review: Bisphosphonates and osteonecrosis of the jaws
    • S.-B. Woo, J.W. Hellstein, and J.R. Kalmar Systematic review: bisphosphonates and osteonecrosis of the jaw Ann Intern Med 144 2006 753 761 (Pubitemid 46780635)
    • (2006) Annals of Internal Medicine , vol.144 , Issue.10 , pp. 753-761
    • Woo, S.-B.1    Hellstein, J.W.2    Kalmar, J.R.3
  • 2
    • 33845960290 scopus 로고    scopus 로고
    • Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates
    • C. Van Poznak, and C.L. Estilo Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates Oncology 20 2006 1053 1062 (Pubitemid 46940833)
    • (2006) Oncology , vol.20 , Issue.9 , pp. 1053-1062
    • Van Poznak, C.1    Estilo, C.2
  • 3
    • 33845961014 scopus 로고    scopus 로고
    • Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
    • DOI 10.1016/j.clinthera.2006.11.015, PII S0149291806002852
    • T. Shih, and C. Lindley Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies Clin Ther 28 2006 1779 1802 (Pubitemid 46038527)
    • (2006) Clinical Therapeutics , vol.28 , Issue.11 , pp. 1779-1802
    • Shih, T.1    Lindley, C.2
  • 5
    • 56749177288 scopus 로고    scopus 로고
    • Bevacizumab-associated osteonecrosis of the jaw
    • S. Greuter, F. Schmid, T. Ruhstaller, and B. Thuerlimann Bevacizumab-associated osteonecrosis of the jaw Ann Oncol 19 12 2008 2091 2092
    • (2008) Ann Oncol , vol.19 , Issue.12 , pp. 2091-2092
    • Greuter, S.1    Schmid, F.2    Ruhstaller, T.3    Thuerlimann, B.4
  • 6
    • 77953534421 scopus 로고    scopus 로고
    • Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer
    • V. Guarneri, D. Miles, N. Robert, V. Diéras, J. Glaspy, and I. Smith Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer Breast Cancer Res Treat 122 1 2010 181 188
    • (2010) Breast Cancer Res Treat , vol.122 , Issue.1 , pp. 181-188
    • Guarneri, V.1    Miles, D.2    Robert, N.3    Diéras, V.4    Glaspy, J.5    Smith, I.6
  • 7
    • 59749100961 scopus 로고    scopus 로고
    • Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone
    • C. Christodoulou, A. Pervena, G. Klouvas, E. Galani, M.E. Falagas, and G. Tsakalos Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone Oncology 76 3 2009 209 211
    • (2009) Oncology , vol.76 , Issue.3 , pp. 209-211
    • Christodoulou, C.1    Pervena, A.2    Klouvas, G.3    Galani, E.4    Falagas, M.E.5    Tsakalos, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.